iliasa

Electro-Optical Sciences: A Speculative Stock with Great Potential

they don't charge for the device. the device costs $25K and remains the property of EOS. they are thinking about charging $5K for the installation and maintenance. they will make their money from the memory cards where the images are stored and share the revenues from the cards with the physician. it's a great product and a very good commercialisation approach that benefits all stakeholders. approval is almost certain. my only concern is on the valuation. based on my assumptions for penetration and utilisation with an expected IRR of 25% this stock is worth $6-15. but it's worth a bet, especially as it is an attractive acquisition target. i don't have any positions on them but I am following closely.


On Jul 09 02:23 PM PalinTologist wrote:

> It's my understanding that they charge for the device itself (relatively
> inexpensive at 5 grand) and then the recording 'card' which is used
> on each patient and stores the data of each test which costs the
> patient around $100 per test, of which MELA keeps $40 and the physician
> keeps $60 (above figures are not exact and only meant to convey the
> general idea, relative to the question asked).
>
> Benefit to the patient is that it is fast and non invasive.
>
> For the busy physician, it allows better customer service to their
> patients who face potential cancer diagnosis and are anxious to find
> out results. As well, it provides better patient flow, i.e. more
> clients=more money as it frees up the physician's time that they
> would otherwise use to do unnecessary, expensive, invasive and time
> intensive biopsies.
>
> I am Long MELA; >1000 shares.
>
> On Jul 09 12:39 PM drd wrote: